UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM EPS
$24.3
YoY Growth
+25.9%
3Y CAGR
+33.1%
5Y CAGR
N/A
Stock quality & Intrinsic value
8/10
15.5% undervalued

United Therapeutics Corporation EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
$0.4
$1.4
$1.6
$0.5
($0.9)
$0.4
$1.9
$3.8
$5.8
$3.5
$7.1
$14.2
$16.3
$9.5
$13.5
($2.4)
$11.7
$10.6
$16.0
$21.0
UTHR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UTHR and see if it's the right time to invest.
Dive in

United Therapeutics Corporation (UTHR) EPS comparison analysis

Crunching data... Almost there!

UTHR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is United Therapeutics Corporation's EPS?

As of today, United Therapeutics Corporation's last 12-month EPS is $24.3, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is United Therapeutics Corporation's EPS growth rate?

Over the last year, United Therapeutics Corporation's EPS growth was 25.9%. The average annual EPS growth rates for United Therapeutics Corporation have been 38.6% over the past three years, N/A over the past five years.

3) Is United Therapeutics Corporation's EPS growth rate Good?

Over the last year, United Therapeutics Corporation's EPS growth was 25.9%, which is higher than industry growth of (0.2%). It indicates that United Therapeutics Corporation's EPS growth is Good.